Neothetics is a clinical-stage specialty pharmaceutical company focused on development and commercialization of therapeutics for the aesthetic market. Our current focus is on localized fat reduction and body contouring. Neothetics’ lead product candidate, LIPO-202, is a injectable treatment for undesirable, localized areas of fat with no downtime and causes no damage below the skin’s surface. Our clinical studies with LIPO-202 do not use local or systemic pain management before or after the procedure.
|Data as of 10/21/17 12:55 am EDT|